or Try an Advanced Search...

    Technical Analysis for HRMY - Harmony Biosciences Holdings, Inc.

    Grade Last Price % Change Price Change
    B 38.34 -1.21% -0.47
    HRMY closed down 1.21 percent on Wednesday, September 18, 2024, on 2.16 times normal volume.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical HRMY trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Slingshot Bullish Bullish Swing Setup -1.21%
    Stochastic Reached Overbought Strength -1.21%
    Upper Bollinger Band Walk Strength -1.21%
    Gapped Up Strength -1.21%
    Overbought Stochastic Strength -1.21%
    Upper Bollinger Band Touch Strength -1.21%
    New 52 Week High Strength -1.08%
    Upper Bollinger Band Walk Strength -1.08%
    Older End-of-Day Signals for HRMY ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Upper Bollinger Band about 17 hours ago
    Possible NR7 about 17 hours ago
    Possible Inside Day about 17 hours ago
    60 Minute Opening Range Breakdown about 18 hours ago
    Down 1% about 18 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    HRMY Chart by TradingView
    Basic chart:

    Profile

    Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Neurological Disorders Stage Pharmaceutical Ethers Urological Disorders Chloroarenes Narcolepsy Piperidines Rare Neurological Disorders Stimulants

    Is HRMY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 10 Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says
    Sep 10 Harmony Biosciences Boosted by Narcolepsy Treatment, Diversification Outlook. UBS Says
    Aug 26 Is Harmony Biosciences (HRMY) a Great Value Stock Right Now?
    Aug 19 Harmony Biosciences: Unnoticed Melodies Of Portfolio Growth And Pipeline Potential
    Aug 16 Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock
    Aug 15 Harmony Biosciences: Advancing An Expanded Pipeline
    Aug 14 Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?
    Aug 9 HRMY vs. REGN: Which Stock Is the Better Value Option?
    Aug 9 Should Value Investors Buy Harmony Biosciences (HRMY) Stock?
    Aug 8 Harmony Biosciences Holdings Second Quarter 2024 Earnings: EPS Beats Expectations
    See more HRMY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 39.73
    52 Week Low 18.6112
    Average Volume 347,798
    200-Day Moving Average 32.18
    50-Day Moving Average 34.94
    20-Day Moving Average 36.78
    10-Day Moving Average 37.55
    Average True Range 1.37
    RSI (14) 64.91
    ADX 34.54
    +DI 25.72
    -DI 12.94
    Chandelier Exit (Long, 3 ATRs) 35.63
    Chandelier Exit (Short, 3 ATRs) 38.85
    Upper Bollinger Bands 39.10
    Lower Bollinger Band 34.47
    Percent B (%b) 0.84
    BandWidth 12.59
    MACD Line 1.10
    MACD Signal Line 0.95
    MACD Histogram 0.1505
    Fundamentals Value
    Market Cap 2.25 Billion
    Num Shares 58.6 Million
    EPS 2.47
    Price-to-Earnings (P/E) Ratio 15.52
    Price-to-Sales 3.82
    Price-to-Book 4.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 40.23
    Resistance 3 (R3) 40.35 39.83 39.92
    Resistance 2 (R2) 39.83 39.35 39.78 39.81
    Resistance 1 (R1) 39.09 39.05 38.83 38.97 39.70
    Pivot Point 38.57 38.57 38.45 38.52 38.57
    Support 1 (S1) 37.83 38.09 37.57 37.71 36.98
    Support 2 (S2) 37.31 37.79 37.26 36.87
    Support 3 (S3) 36.57 37.31 36.77
    Support 4 (S4) 36.45